| Variables |
TTS (n=103) |
ACS (n=422) |
p value* |
| Drugs on admission. n (%) | |||
| Beta-blocker | 41 (41.8) | 133 (31.8) | 0.06 |
| ACE inhibitor | 42 (42.9) | 106 (25.2) | <0.01 |
| Aldosterone inhibitor | 1 (1.0) | 2 (0.5) | 0.52 |
| Aspirin | 31 (31.6) | 117 (27.9) | 0.56 |
| Therapeutic anticoagulation | 10 (10.3) | 24 (5.7) | 0.10 |
| Drugs on discharge. n (%) | |||
| Beta-blocker | 103 (100.0) | 422 (100.0) | |
| ACE inhibitor | 67 (65.0) | 316 (74.9) | 0.04 |
| Aldosterone inhibitor | 2 (1.9) | 5 (1.2) | 0.55 |
| Aspirin | 47 (45.6) | 414 (98.1) | <0.01 |
| Clopidogrel | 7 (6.8) | 372 (88.2) | <0.01 |
| Aspirin + clopidogrel | 7 (6.8) | 369 (87.4) | <0.01 |
| Cumarine | 10 (9.7) | 10 (2.4) | <0.01 |
| Heparin | 16 (15.5) | 25 (5.9) | 0.01 |
| Factor Xa inhibitors | 5 (4.9) | 0 (0) | <0.01 |
*p values for the comparison between TTS and ACS.
ACE, angiotensin-converting-enzyme; ACS, acute coronary syndrome; BMI, body-mass-index; BP, blood pressure; COPD, chronic obstructive pulmonary disease; ECG, electrocardiogram; EF, ejection fraction; IQR, inter quartile range; LVEF, left ventricular ejection fraction; SD, standard deviation; TTS, Takotsubo syndrome.